Colgate-Palmolive Company (CL)
| Market Cap | 73.87B +16.6% |
| Revenue (ttm) | 21.05B +5.2% |
| Net Income | 2.04B -29.9% |
| EPS | 2.53 -28.8% |
| Shares Out | 797.17M |
| PE Ratio | 36.57 |
| Forward PE | 23.69 |
| Dividend | $2.12 (2.29%) |
| Ex-Dividend Date | Oct 20, 2026 |
| Volume | 8,170,963 |
| Open | 94.26 |
| Previous Close | 92.78 |
| Day's Range | 92.12 - 95.33 |
| 52-Week Range | 74.55 - 99.33 |
| Beta | 0.32 |
| Analysts | Buy |
| Price Target | 98.10 (+5.86%) |
| Earnings Date | Oct 30, 2026 |
About CL
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells i... [Read more]
Financial Performance
In 2025, Colgate-Palmolive Company's revenue was $20.38 billion, an increase of 1.40% compared to the previous year's $20.10 billion. Earnings were $2.13 billion, a decrease of -26.20%.
Financial StatementsAnalyst Summary
According to 21 analysts, the average rating for CL stock is "Buy." The 12-month stock price target is $98.1, which is an increase of 5.86% from the latest price.
News
Colgate-Palmolive price target lowered to $106 from $109 at UBS
UBS lowered the firm’s price target on Colgate-Palmolive (CL) to $106 from $109 and keeps a Buy rating on the shares.
Colgate-Palmolive price target lowered to $100 from $102 at BofA
BofA lowered the firm’s price target on Colgate-Palmolive (CL) to $100 from $102 and keeps a Buy rating on the shares. Many of the same debates weighing on consumer staples…
Tom's of Maine Introduces Hydroxyapatite Toothpaste to Meet Rising Consumer Demand
Fluoride-free, anti-sensitivity toothpaste — formulated with naturally derived Calcium Carbonate and Arginine — for whitening and sensitivity relief KENNEBUNK, Maine, Sept. 23, 2026 /PRNewswire/ -- As...
Colgate-Palmolive price target lowered to $95 from $98 at Piper Sandler
Piper Sandler lowered the firm’s price target on Colgate-Palmolive (CL) to $95 from $98 and keeps an Overweight rating on the shares. The firm says momentum outside the U.S. remains…
Colgate-Palmolive Declares Regular Quarterly Dividend
NEW YORK--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.53 per common share, payable on November 13, 2026, to shareholde...
Colgate-Palmolive Stock (CL) Dips on Plan to Sell Personal Care Brands
The company makes popular consumer products.
Colgate-Palmolive exploring sale of certain personal care brands, Reuters says
Colgate-Palmolive (CL) is weighing a sale of certain mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, and is working with Goldman Sachs (GS) on the process, Reuters...
Colgate-Palmolive seeks to divest some personal care brands, sources say
Colgate-Palmolive is exploring a sale of certain mass-market personal care brands, including Softsoap, Irish Spring and Speed Stick, sources familiar with the matter told Reuters.
Colgate-Palmolive Company Transcript: Barclays 19th Annual Global Consumer Conference
Momentum from the 2025 plan is fueling a focus on innovation, premiumization, and selective investment, especially in emerging markets. North America is undergoing a strategic reset with increased innovation and targeted promotional tactics, while Hill’s and emerging markets drive growth. SGPP enables resource reallocation and operational flexibility.
Colgate-Palmolive Webcasts Fireside Chat at the Barclays 2026 Global Consumer Staples Conference
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, will participate in a fireside chat on Wednesday, September 9, 2026 at 8:15 a.m. ET at the Barclays 20...
Colgate-Palmolive price target raised to $104 from $102 at RBC Capital
RBC Capital analyst Nik Modi raised the firm’s price target on Colgate-Palmolive (CL) to $104 from $102 and keeps an Outperform rating on the shares. The company reported a mixed…
Colgate-Palmolive price target raised to $101 from $99 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Colgate-Palmolive (CL) to $101 from $99 and keeps a Buy rating on the shares.
Colgate-Palmolive price target raised to $109 from $106 at UBS
UBS raised the firm’s price target on Colgate-Palmolive (CL) to $109 from $106 and keeps a Buy rating on the shares.
Colgate-Palmolive price target raised to $104 from $100 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Colgate-Palmolive (CL) to $104 from $100 and keeps an Overweight rating on the shares. The firm, which generally views the company’s Q2…
Colgate-Palmolive price target raised to $90 from $85 at TD Cowen
TD Cowen raised the firm’s price target on Colgate-Palmolive (CL) to $90 from $85 and keeps a Hold rating on the shares. The firm updated its model following inline results…
Colgate-Palmolive price target lowered to $103 from $104 at JPMorgan
JPMorgan lowered the firm’s price target on Colgate-Palmolive (CL) to $103 from $104 and keeps an Overweight rating on the shares. The firm says the company’s international growth continues to…
Colgate-Palmolive Company Earnings Call Transcript: Q2 2026
Strong top and bottom-line growth was achieved, led by emerging markets and innovation, with gross margin expanding and free cash flow up 18%. U.S. softness prompted targeted actions, while robust performance in Europe, Latin America, and Hill's pet business supported results.
Colgate-Palmolive Company Earnings release: Q2 2026
Colgate-Palmolive Company released its Q2 2026 earnings on July 31, 2026, summarizing the period's financial results.
Colgate-Palmolive Company Slides: Q2 2026
Colgate-Palmolive Company has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 31, 2026.
Colgate-Palmolive Company Quarterly report: Q2 2026
Colgate-Palmolive Company has published its Q2 2026 quarterly earnings report on July 31, 2026.
Colgate-Palmolive Company Prepared remarks: Q2 2026
Colgate-Palmolive Company filed a regulatory document on July 31, 2026 disclosing important business information.
Colgate-Palmolive reaffirms annual sales forecast on weak North America demand
Colgate-Palmolive on Friday reaffirmed its annual sales forecast even after posting a quarterly rise as the toothpaste maker continues to grapple with muted demand in North America, sending its shar...
Colgate-Palmolive Sales Rise Despite Choppy Backdrop
Colgate-Palmolive recorded higher sales in the second quarter, despite a choppy consumer environment.
Colgate Announces 2nd Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL): Net sales increased 4.9%; Organic sales* increased 2.4%, including a 0.4% negative impact from lower private label pet food sales GAAP E...
Colgate-Palmolive price target raised to $87 from $80 at Barclays
Barclays analyst Lauren Lieberman raised the firm’s price target on Colgate-Palmolive (CL) to $87 from $80 and keeps an Equal Weight rating on the shares. The firm adjusted targets in…